FDA regulates a range of products which includes food (human\nand animal consumption), medical products (drugs, devices and biological\nproducts), radiation-emitting electronic products, tobacco products and\ncosmetics. All imported shipments of FDA regulated products are evaluated by\nFDA and needs to comply with same regulations as of domestic products. The products that are offered into U.S\nincluding personal items must be declared to U.S. Customs and Border Protection\n(CBP). CBP will refers all FDA \u2013regulated products to FDA for review. Mostly,\nimporters will hire a custom broker to help them in submitting necessary entry\ndocuments and applicable payments to CBP on behalf of the importer. FDA regulated products are refused to enter\nin US commerce, if they appear to be adulterated, misbranded, or restricted for\nSale. Refused products needs to be\ndestroyed or exported from U.S within 90 days. <\/p>\n\n\n\n
MEDICAL DEVICE IMPORTATION<\/strong><\/p>\n\n\n\n Foreign medical device manufacturers are required to meet\napplicable US FDA medical device regulations in order to import devices into\nthe U.S although the product is permitted for marketing in another country. The following are the requirements which FDA\nchecks at the time of importation<\/p>\n\n\n\n The Initial importer of the device are required to register\ntheir establishment with FDA. <\/p>\n\n\n\n As per FDA, an initial importer is any importer who furthers the marketing of a device from a foreign manufacturer to the person who makes the final delivery or sale of the device to the ultimate consumer or user, but does not repackage, or otherwise change the container, wrapper, or labeling of the device or device package.\u00a0 FDA medical device establishment registration and listing can be found at https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfRL\/rl.cfm<\/a><\/p>\n\n\n\n Manufacturers, Initial importers and device user facilities\nare subject to Medical Device Reporting (MDR) regulation, where they have to\nreport device-related adverse events and problems to FDA. Importers are\nrequired to maintain a MDR event file for each adverse event and also they have\nto forward all product complaints (MDR and non MDR events) to the manufacturer.<\/p>\n\n\n\n Medical devices that are imported into the United States\nmust meet Custom Border Protection (CBP) requirements in addition to FDA\nregulations.<\/p>\n\n\n\n Liberty Management Group<\/a>, a leading FDA consulting group in the United States provides assistance with medical device establishment registration, device listing, medical device label review and US agent service for foreign medical device establishment firms.<\/p>\n\n\n\n Sudha S<\/p>\n\n\n\n Regulatory Consultant<\/p>\n\n\n\n Mail: office@libertymanagement.us<\/p>\n\n\n\n http:\/\/www.fdahelp.us<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" FDA regulates a range of products which includes food (human and animal consumption), medical products (drugs, devices and biological products), radiation-emitting electronic products, tobacco products and cosmetics. All imported shipments of FDA regulated products are evaluated by FDA and needs to comply with same regulations as of domestic products. The products that are offered into … Continue reading “BASICS OF IMPORTATION \u2013 MEDICAL DEVICES”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[7,29,28],"class_list":["post-129","post","type-post","status-publish","format-standard","hentry","category-fda-registration-medical-device","tag-fda-medical-device-labeling","tag-fda-medical-device-registration","tag-us-fda-registration"],"_links":{"self":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/comments?post=129"}],"version-history":[{"count":1,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/129\/revisions"}],"predecessor-version":[{"id":130,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/129\/revisions\/130"}],"wp:attachment":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/media?parent=129"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/categories?post=129"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/tags?post=129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}